1. Home
  2. ELVR vs CTMX Comparison

ELVR vs CTMX Comparison

Compare ELVR & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELVR

Sayona Mining Limited American Depository Shares

N/A

Current Price

$41.35

Market Cap

596.4M

Sector

Industrials

ML Signal

N/A

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.89

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELVR
CTMX
Founded
2000
2008
Country
Australia
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
596.4M
596.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ELVR
CTMX
Price
$41.35
$3.89
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.50
AVG Volume (30 Days)
169.8K
2.4M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.22
EPS
N/A
0.24
Revenue
$146,440,045.00
$113,631,000.00
Revenue This Year
$11.13
N/A
Revenue Next Year
$13.58
N/A
P/E Ratio
N/A
$16.28
Revenue Growth
11.20
N/A
52 Week Low
$15.55
$0.40
52 Week High
$41.55
$4.62

Technical Indicators

Market Signals
Indicator
ELVR
CTMX
Relative Strength Index (RSI) N/A 51.40
Support Level N/A $3.66
Resistance Level N/A $4.20
Average True Range (ATR) 0.00 0.24
MACD 0.00 -0.04
Stochastic Oscillator 0.00 43.84

Price Performance

Historical Comparison
ELVR
CTMX

About ELVR Sayona Mining Limited American Depository Shares

Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is the identification, acquisition, and evaluation of mineral exploration assets, focusing on lithium. The projects of the company include the Moblan Lithium Project, the Carolina Lithium Project, the Ewoyaa Lithium Project, North American Lithium, and other projects. The company also holds an interest in a tenement portfolio in the Pilbara region, prospective for gold and lithium.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: